123 related articles for article (PubMed ID: 31876807)
1. Solitary Cerebellar Metastasis of Ovarian Cancer Detected by FDG PET/CT.
Hou G; Jiang Y; Cheng X
Clin Nucl Med; 2020 Mar; 45(3):230-231. PubMed ID: 31876807
[TBL] [Abstract][Full Text] [Related]
2. Recurrent Ovarian Cancer Presenting as a Solitary Chest Wall Metastasis Revealed by FDG PET/CT.
Shen G; Kuang A
Clin Nucl Med; 2022 Apr; 47(4):365-366. PubMed ID: 35143461
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET/CT Findings of Ovarian Mesothelioma: A Case Study.
Sun R; Chen Y; Huang Z
Clin Nucl Med; 2019 Nov; 44(11):925-926. PubMed ID: 31584489
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of CA125 and its kinetic parameters and positron emission tomography/computed tomography (PET/CT) with fluorodeoxyglucose ([
Palomar Muñoz A; Cordero García JM; Talavera Rubio P; García Vicente AM; González García B; Bellón Guardia ME; Soriano Castrejón Á; Aranda Aguilar E
Med Clin (Barc); 2018 Aug; 151(3):97-102. PubMed ID: 29276012
[TBL] [Abstract][Full Text] [Related]
5. The role of F18-FDG PET/CT in predicting secondary optimal de-bulking in patients with recurrent ovarian cancer.
Amit A; Hodes A; Lavie O; Keidar Z; Matanes E; Lowenstein L
Surg Oncol; 2017 Dec; 26(4):347-351. PubMed ID: 29113651
[TBL] [Abstract][Full Text] [Related]
6. Isolated splenic metastasis of ovarian cancer detected with 18F-FDG PET/CT.
Lee DH; Yoon JK; Lee SJ; Jo KS; Yoon SH; An YS
Clin Nucl Med; 2014 Apr; 39(4):349-51. PubMed ID: 23640230
[TBL] [Abstract][Full Text] [Related]
7. FDG PET/CT Findings in a Patient With Ovarian Metastasis of Pheochromocytoma.
Jiang Y; Hou G; Cheng X; Zhu Z; Cheng W
Clin Nucl Med; 2020 Nov; 45(11):931-932. PubMed ID: 32910043
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of integrated ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients.
Lee YJ; Kim YM; Jung PS; Lee JJ; Kim JK; Kim YT; Nam JH
J Gynecol Oncol; 2018 May; 29(3):e36. PubMed ID: 29400023
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG-PET/CT can identify histopathological non-responders to platinum-based neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
Vallius T; Peter A; Auranen A; Carpén O; Kemppainen J; Matomäki J; Oksa S; Roering P; Seppänen M; Grénman S; Hynninen J
Gynecol Oncol; 2016 Jan; 140(1):29-35. PubMed ID: 26515076
[TBL] [Abstract][Full Text] [Related]
10. Value of [18F]FDG-PET/CT and CA125, serum levels and kinetic parameters, in early detection of ovarian cancer recurrence: Influence of histological subtypes and tumor stages.
Palomar Muñoz A; Cordero García JM; Talavera Rubio MDP; García Vicente AM; Pena Pardo FJ; Jiménez Londoño GA; Soriano Castrejón Á; Aranda Aguilar E
Medicine (Baltimore); 2018 Apr; 97(17):e0098. PubMed ID: 29702969
[TBL] [Abstract][Full Text] [Related]
11. Novel perioperative imaging with 18F-FDG PET/CT and intraoperative 18F-FDG detection using a handheld gamma probe in recurrent ovarian cancer.
Cohn DE; Hall NC; Povoski SP; Seamon LG; Farrar WB; Martin EW
Gynecol Oncol; 2008 Aug; 110(2):152-7. PubMed ID: 18539314
[TBL] [Abstract][Full Text] [Related]
12. Ovarian Metastasis From Diffuse Epithelioid Malignant Mesothelioma Revealed by 18 F-FDG PET/CT.
Hou G; Jin Y; Peng P; Zheng R
Clin Nucl Med; 2023 Aug; 48(8):735-736. PubMed ID: 37276544
[TBL] [Abstract][Full Text] [Related]
13. [A case of solitary splenic metastasis from an ovarian cancer 12 years after primary resection].
Hasegawa H; Naitoh H; Tsuchihashi H; Okada K; Furukawa H; Hanasawa K
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1799-803. PubMed ID: 20841951
[TBL] [Abstract][Full Text] [Related]
14. Ovarian Metastasis as Initial Presentation of Pancreatic Carcinoma on FDG PET/CT.
Hou G; Jiang Y; Li F; Cheng X
Clin Nucl Med; 2020 Apr; 45(4):306-307. PubMed ID: 31876828
[TBL] [Abstract][Full Text] [Related]
15. [Peritoneal carcinomatosis from ovarian cancer: role of 18F-FDG-PET/CT and CA125].
Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Stabile Ianora AA; Giganti M; Niccoli Asabella A
Recenti Prog Med; 2012 Nov; 103(11):510-4. PubMed ID: 23096741
[TBL] [Abstract][Full Text] [Related]
16. [F-18-FDG positron emission tomography in the diagnosis of ovarian recurrence. Comparison with CT scan and CA 125].
García Velloso MJ; Boán García JF; Villar Luque LM; Aramendía Beitia JM; López García G; Richter Echeverría JA
Rev Esp Med Nucl; 2003; 22(4):217-23. PubMed ID: 12846945
[TBL] [Abstract][Full Text] [Related]
17. Recurrent ovarian carcinoma presenting as a solitary sternal metastasis on FDG PET/CT.
Ho L; Kaushik A; Zhang W; Wassef H
Clin Nucl Med; 2011 Aug; 36(8):733-4. PubMed ID: 21716037
[TBL] [Abstract][Full Text] [Related]
18. Role of
Dolci C; Ceppi L; Guerra L; Crivellaro C; Lamanna M; Adorni M; Elisei F; Bonazzi CM; Sina F; Fruscio R; Messa C
Int J Gynecol Cancer; 2019 Oct; 29(8):1298-1303. PubMed ID: 31366569
[TBL] [Abstract][Full Text] [Related]
19. Clinical Value of
Hynninen J; Laasik M; Vallius T; Kemppainen J; Grönroos S; Virtanen J; Casado J; Hautaniemi S; Grenman S; Seppänen M; Auranen A
Clin Oncol (R Coll Radiol); 2018 Aug; 30(8):507-514. PubMed ID: 29753662
[TBL] [Abstract][Full Text] [Related]
20. FDG-PET/CT to predict optimal primary cytoreductive surgery in patients with advanced ovarian cancer: preliminary results.
Alessi A; Martinelli F; Padovano B; Serafini G; Lorusso D; Lorenzoni A; Ditto A; Lecce F; Mira M; Donfrancesco C; Raspagliesi F; Crippa F
Tumori; 2016; 102(1):103-7. PubMed ID: 26350201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
